The fate of integrated treatment: Whatever happened to the biopsychosocial psychiatrist?

American Journal of Psychiatry

Volumn 158, Issue 12, 2001, Pages 1956-1963

  Gabbard, G O ^a   Kay, J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CLOMIPRAMINE; IMIPRAMINE; METHYLPHENIDATE; NEFAZODONE; NORTRIPTYLINE;

BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HUMAN; PRIORITY JOURNAL; PSYCHIATRIST; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RESIDENCY EDUCATION; REVIEW; SOCIAL PSYCHOLOGY;

BIOLOGICAL PSYCHIATRY; CLINICAL TRIALS; COMBINED MODALITY THERAPY; COMMUNITY PSYCHIATRY; FORECASTING; HUMANS; MENTAL DISORDERS; PHYSICIAN'S ROLE; PSYCHOTHERAPY; PSYCHOTROPIC DRUGS; TREATMENT OUTCOME;

EID: 0035185478     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.158.12.1956     Document Type: Review

References (70)

1. The biopsychosocial model and medical education: Who are to be the teachers?
2. Psychiatric patients and treatments in 1997: Findings from the American Psychiatric Association Practice Research Network
3. Managed care and the future of psychiatry
4. Redefining the role of psychiatry in medicine
5. Research and the practice of psychotherapy
6. Individual psychotherapy and persons with serious mental illness: The clients' perspective
7. The effectiveness of psychotherapy: The Consumer Reports study
8. Effectiveness of partial hospitalization in the treatment of borderline personality disorder: A randomized controlled trial
9. Treatment of borderline personality disorder with psychoanalytically oriented partial hospitalization: An 18-month follow-up
10. Outcome of child psychotherapy as a function of frequency of session
11. Varieties of long-term outcome among patients in psychoanalysis and long-term psychotherapy: A review of findings in the Stockholm Outcome of Psychoanalysis and Psychotherapy Project (STOPP)
12. A controlled study of the psychoanalytic treatment of brittle diabetes
13. Short-term dynamically oriented psychotherapy: A review and meta-analysis
14. Empirical evidence and psychotherapy: A growing scientific base
15. The economic impact of psychotherapy: A review
16. The efficacy of dynamic psychotherapies: Is it true that "everyone has won and all must have prizes"?
17. Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia, II: Two-year effects of a controlled study on relapse and adjustment
18. Randomized controlled trial of family interventions for 78 first-episode male schizophrenic patients: An 18-month study in Suzhou, Jiangsu
19. Three-year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates
20. Three-year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients
21. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression
22. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: A randomized controlled trial in patients older than 59 years
23. Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations
24. Combined medication and psychotherapy
25. Short- and longterm effects of medication and psychotherapy in the brief treatment of depression: Further analyses of data from the NIMH TDCRP
26. Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: Clinical symptoms and functional impairments
27. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial
28. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder
29. Does brief dynamic psychotherapy reduce the relapse rate of panic disorder?
30. Combined behavior and pharmacological treatment of anxiety disorders
31. Medication and psychotherapy in the treatment of bulimia nervosa
32. Psychopharmacology in conjunction with psychotherapy
33. National Institute of Mental Health Treatment of Depression Collaborative Research Program: General effectiveness of treatments
34. The role of therapeutic alliance in psychotherapy and pharmacotherapy outcome: Findings in the National Institute of Mental Health Treatment of Depression Collaborative Research Program
35. Treatment adherence
36. Noncompliance in community psychiatry: A review of clinical interventions
37. The practitioner, the patient and resistance to change: Recent ideas on compliance
38. The patientprovider relationship: Attachment theory and adherence to treatment in diabetes
39. Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders
40. A cognitive-behavioral program to improve compliance with medication in patients with schizophrenia
41. Effects of psychoeducational intervention for married patients with bipolar disorder and their spouses
42. Are psychiatrists cost-effective? An analysis of integrated versus split treatment
43. Outpatient utilization patterns of integrated and split psychotherapy and pharmacotherapy for depression
44. Combined psychotherapy and pharmacotherapy
45. A neurobiologically informed perspective on psychotherapy
46. Linking mind and brain in the study of mental illnesses: A project for a scientific psychopathology
47. A new intellectual framework for psychiatry
48. Biology and the future of psychoanalysis: A new intellectual framework for psychiatry revisited
49. Converging sectors of psychoanalysis and neurobiology: Mutual challenge and opportunity
50. Psychotherapy and pharmacotherapy: Conceptual issues
51. A cognitive therapy approach to medication compliance
52. Clinicians' experiences in combining medication and psychotherapy in the treatment of borderline patients
53. Combining medication and psychotherapy
54. Split treatment: Clarity between psychiatrists and psychotherapists, part I
55. Split treatment: Clarity between psychiatrists and psychotherapists, part II
56. Divided treatment: Legal implications and risks
57. Interpersonal psychotherapy and antidepressant medication: Evaluation of a sequential treatment strategy in women with recurrent major depression
58. Some neurobiological aspects of psychotherapy: A review
59. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder
60. Change in monoamine transporter density related to clinical recovery: A case-control study
61. Regional brain metabolic changes in patients with major depression teated with either paroxetine or interpersonal therapy
62. Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride
63. Integrated treatment: An overview